Suppr超能文献

在基于价值的医疗保健时代,综合药师如何在炎症性肠病的管理中增加价值?

How Does an Integrated Pharmacist Add Value in the Management of Inflammatory Bowel Disease in the Era of Values-Based Healthcare?

作者信息

Hilley Patrick, Wong Darren, De Cruz Peter

机构信息

Department of Gastroenterology, The Austin Hospital, Melbourne, Australia.

Department of Medicine, Austin Academic Centre, University of Melbourne, Melbourne, Australia.

出版信息

Inflamm Bowel Dis. 2025 May 12;31(5):1419-1429. doi: 10.1093/ibd/izae196.

Abstract

The World Health Organization has recommended that the management of chronic diseases such as inflammatory bowel disease (IBD) should be undertaken using an integrated approach delivered by a multidisciplinary team. Although the composition of an IBD multidisciplinary team has been well described, the inclusion of an IBD pharmacist as a core member has been more recent, with variable uptake within IBD services internationally. While pharmacists continue to play the traditional role of safe prescribing and monitoring of immunosuppressive therapies, their role within the IBD team is rapidly expanding; however, the value, in terms of both clinical outcomes as well as financial savings (where available), which they add to IBD services has been less well described. In this narrative review, we perform a comprehensive evaluation of the literature detailing the expanding roles that IBD pharmacists play and describe opportunities that exist for integrated pharmacists to add value to IBD service delivery. Medication and adherence counseling, immunosuppressive monitoring, uptake of biosimilars, therapeutic drug monitoring, health promotion and prevention appear to be key areas where integrated pharmacists can add the most value to IBD patients and services. In particular, integrated IBD pharmacists can improve patient outcomes via rigorous monitoring pre and post initiation of drug therapies; focused medication counseling; advice on improving adherence; implementation of novel approaches to medication usage, and; strategies to help sustain IBD service delivery. These data can be used to further build a case for those seeking to add pharmacists to their team/services. Future studies should focus on evaluating the impact of an integrated IBD pharmacist on quality-of-care delivery together with the clinical and financial value added to IBD services compared to services that lack an integrated IBD pharmacist role.

摘要

世界卫生组织建议,应采用多学科团队提供的综合方法来管理炎症性肠病(IBD)等慢性病。尽管IBD多学科团队的组成已有详细描述,但将IBD药剂师作为核心成员纳入团队的做法出现得较晚,在国际上IBD服务中的采用情况也各不相同。虽然药剂师继续发挥安全开具和监测免疫抑制疗法的传统作用,但他们在IBD团队中的作用正在迅速扩大;然而,他们为IBD服务带来的临床结果和财务节省(如适用)方面的价值,描述得还不够充分。在这篇叙述性综述中,我们对文献进行了全面评估,详细阐述了IBD药剂师不断扩大的作用,并描述了综合药剂师为IBD服务带来价值的机会。药物和依从性咨询、免疫抑制监测(生物类似药的使用、治疗药物监测)、健康促进和预防似乎是综合药剂师可为IBD患者和服务带来最大价值的关键领域。特别是,综合IBD药剂师可以通过在药物治疗开始前和开始后进行严格监测、提供有针对性的药物咨询、提供改善依从性的建议、实施新的用药方法以及帮助维持IBD服务提供的策略来改善患者预后。这些数据可用于为那些寻求将药剂师纳入其团队/服务的人进一步提供依据。未来的研究应侧重于评估综合IBD药剂师对护理质量的影响,以及与缺乏综合IBD药剂师角色的服务相比,为IBD服务带来的临床和财务价值。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验